History of Lyka Labs Ltd.
YEAR EVENTS 1976 - The Comp. was incorporated on 29th December as a private Limited Comp. & Converted into a Public Limited Comp. on 19th December, 1985.
- The Comp. alongwith Gujarat Industrial Investment Corporation Limited promoted a new company, Gujarat Lyka Organics Limited, at Ankleshwar in Gujarat for manufacture of Semi-Synthetic Penicilline.
1993 - The Comp. proposed to offer 20,60,000 No. of Equity Shares of Rs. 10/- each at an issue price not exceeding Rs. 35/- per share on the basis of one Equity Share for every two Equity Shares.
1994 - The Comp. is negtiating tieup arrangements with internationally reputed manufactureres for marketing & manufacturing its products in India.
1995 - Government of India has selected the Comp. for award of the Certificate of Merit for excellent export performance during 1993-94. Further CHEMEXCIL has also selected the Comp. for the SECOND AWARD for outstanding export performance during 1993-94.
- The Comp. has commenced production at its new formulation plant at Tarapur, have been designed with state-of-the-art technology to meet with the International Standards of Good Manufacturing Practices & with Total Quality Management Systems [TOMs].
- The Comp. has also set up additional manufacturing facility for ointment at Ankleshwar
- Lyka Exports Limited became a subsidiary of Company.
- The Comp. allotted 1,50,000 Equity Shares to Foreign Institutional Investors on private placement basis & 40,000 Equity Shares to the Promoters.
1997 - The Comp. during the period has allotted 5,65,000 Secured Redeemable Non-Convertible Debentures of Rs.100/- each aggregating to Rs.5.65 crores.
- Lyka Labs Limited has entered into the marketing of skin cream which is used to treat dry skin conditions.
- The Comp. has recently launched a rubefacient, too.
1998 - The Company Administrative Office & Corporate Quality Assurance at Mumbai & Plant at Tarapur has been awarded ISO 9002 Certification for its Quality Management System by SGS Yarsley International Certification Services Limited, U.K.
1999 - Lyka Labs has launched a product-rationalisation exercise to exit cardiovasculars which is a non-focus area, sources opine.
- The Comp. recently launched dermatological skin ointment Cetraben.
2000 - The Comp. to issue on preferential basis 30,00,000 No. of equity shares of Rs. 10/- each on preferential allotment to Financial Institutions/FIIs/MFs.
2003 -Entered into an agreement with BDR Pharmaceuticals International to form a 50:50 joint venture. The new Comp. will be focussed on enhancing Lyka export business to developed & developing countries, which at present being handled by Lyka.
-Lyka Labs marketing tie-up with Bio X-Healthcare
-Lyka Labs Ltd has informed that the Comp. has decided to dis-invest its holding in its subsidary, Lyka Exports limited In view of this, Lyka Exports limited will cease to be its subsidary.
2005
-Lyka Labs launches BIOXTRA Toothpaste and Gel
-Clearwater Capital Partners Limited joined hands with Lyka Labs Ltd
2006
-Lyka Labs Ltd has informed that Lyka Labs Ltd has changed the Registrar & Transfer Agent from MCS Ltd to Sharex Dynamic [ India s] Limited, Unit No.1, Luthra Ind. Premises, Andheri Kurla Road, Safed Pool, Andheri [ East s] Mumbai 400 072, Tel No. 2851 5606/44 Fax 2851 2885, with effect from September 30, 2006.
2008
-Lyka Labs Ltd has appointed Mr. D G Shah as Additional Director of Company.
